Abstract
Cite the current indications, basic clinical pharmacology, and rationale for development of the new oral anticoagulants. Explain the potential risk for drug-drug interactions between the new oral anticoagulants and drugs commonly used in cancer patients.
Cite
CITATION STYLE
APA
Short, N. J., & Connors, J. M. (2014). New Oral Anticoagulants and the Cancer Patient. The Oncologist, 19(1), 82–93. https://doi.org/10.1634/theoncologist.2013-0239
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free